Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 5
2005 7
2006 7
2007 5
2008 8
2009 7
2010 14
2011 6
2012 13
2013 6
2014 11
2015 3
2016 10
2017 10
2018 5
2019 5
2020 5
2021 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Diet and nutritional factors in inflammatory bowel diseases.
Owczarek D, Rodacki T, Domagała-Rodacka R, Cibor D, Mach T. Owczarek D, et al. Among authors: mach t. World J Gastroenterol. 2016 Jan 21;22(3):895-905. doi: 10.3748/wjg.v22.i3.895. World J Gastroenterol. 2016. PMID: 26811635 Free PMC article. Review.
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB; MODIFY I and MODIFY II Investigators. Wilcox MH, et al. N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615. N Engl J Med. 2017. PMID: 28121498 Free article. Clinical Trial.
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, Kremer AE, Zigmond E, Andreone P, Gordon SC, Bowlus CL, Lawitz EJ, Aspinall RJ, Pratt DS, Raikhelson K, Gonzalez-Huezo MS, Heneghan MA, Jeong SH, Ladrón de Guevara AL, Mayo MJ, Dalekos GN, Drenth JPH, Janczewska E, Leggett BA, Nevens F, Vargas V, Zuckerman E, Corpechot C, Fassio E, Hinrichsen H, Invernizzi P, Trivedi PJ, Forman L, Jones DEJ, Ryder SD, Swain MG, Steinberg A, Boudes PF, Choi YJ, McWherter CA; ENHANCE Study Group*. Hirschfield GM, et al. Hepatology. 2023 Aug 1;78(2):397-415. doi: 10.1097/HEP.0000000000000395. Epub 2023 Apr 6. Hepatology. 2023. PMID: 37386786 Free PMC article. Clinical Trial.
Viral hepatitis C.
Czepiel J, Biesiada G, Mach T. Czepiel J, et al. Among authors: mach t. Pol Arch Med Wewn. 2008 Dec;118(12):734-40. Pol Arch Med Wewn. 2008. PMID: 19202952 Free article. Review.
Biological therapy of inflammatory bowel disease.
Owczarek D, Cibor D, Szczepanek M, Mach T. Owczarek D, et al. Among authors: mach t. Pol Arch Med Wewn. 2009 Jan-Feb;119(1-2):84-8. Pol Arch Med Wewn. 2009. PMID: 19341184 Free article. Review.
Lyme disease: review.
Biesiada G, Czepiel J, Leśniak MR, Garlicki A, Mach T. Biesiada G, et al. Among authors: mach t. Arch Med Sci. 2012 Dec 20;8(6):978-82. doi: 10.5114/aoms.2012.30948. Epub 2012 Oct 8. Arch Med Sci. 2012. PMID: 23319969 Free PMC article.
134 results